Human TRAIL R2/TNFRSF10B Biotinylated Antibody
Catalog # BAF631 | R&D Systems, Inc. a Bio-Techne Brand
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Summary for Human TRAIL R2/TNFRSF10B Biotinylated Antibody
Immunogen
Ala54-Glu182
Accession # Q6FH58
Specificity
Clonality
Host
Isotype
Applications for Human TRAIL R2/TNFRSF10B Biotinylated Antibody
Western Blot
Sample: Recombinant Human TRAIL R2/TNFRSF10B Fc Chimera (Catalog # 631-T2)
Published Applications
Read 4 publications using BAF631 in the following applications:
Formulation, Preparation and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TRAIL R2/TNFRSF10B
Human TRAIL R2, also called DR5 and TRICK 2 is a type 1, TNF R family, membrane protein which is a receptor for TRAIL (APO2 ligand). In the new TNF superfamily nomenclature, TRAIL R2 is referred to as TNFRSF10B. TRAIL R2 cDNA encodes a 440 amino acid residue precursor protein containing extracellular cysteine-rich domains, a transmembrane domain and a cytoplasmic death domain. Among TNF receptor family proteins, TRAIL R2 is most closely related to TRAIL R1/DR4, sharing 55% amino acid sequence identity. Binding of trimeric TRAIL to TRAIL R2 induces apoptosis. The induction of apoptosis likely requires oligomerization of the receptor. The human TRAIL R2/Fc chimera neutralizes the ability of TRAIL to induce apoptosis. Besides TRAIL R2, an additional TRAIL R1/DR4, which tranduces apoptosis signaling, and two TRAIL decoy receptors, which antagonize TRAIL-induced apoptosis, have been reported.
Product Documents for Human TRAIL R2/TNFRSF10B Biotinylated Antibody
Product Specific Notices for Human TRAIL R2/TNFRSF10B Biotinylated Antibody
For research use only
Citations for Human TRAIL R2/TNFRSF10B Biotinylated Antibody (4)
Citations are publications that use Bio-Techne products. Selected citations for Human TRAIL R2/TNFRSF10B Biotinylated Antibody include:
-
Species: Human
Sample Types: Whole Cells
Applications: Flow CytometryGatti L et al. (2013-12-17), Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. J Pharmacol Exp Ther, 2013-1348(3):360-71.
PMID: 24345465 -
Species: Human
Sample Types: Whole Cells
Applications: Flow CytometryReddy RM et al. (2007-01-01), Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. Apoptosis, 2007-012(1):55-71.
PMID: 17136498 -
Species: Human
Sample Types: Whole Cells
Applications: Flow CytometryTsai WS et al. (2006-12-01), Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin. Mol. Cancer Ther., 2006-15(12):2977-90.
PMID: 17172403 -
Species: Human
Sample Types: Whole Cells
Applications: Flow CytometryMouzakiti A et al. (2003-07-01), Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Burkitt's lymphoma cell lines. Br. J. Haematol., 2003-0122(1):61-9.
PMID: 12823346
There are no citations that match your criteria.
Reconstitution Calculator
The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.